Literature DB >> 8427715

Human immunodeficiency virus type I provirus is demonstrated in peripheral blood monocytes in vivo: a study utilizing an in situ polymerase chain reaction.

O Bagasra1, R J Pomerantz.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) infects a variety of cell types in vivo. Monocyte/macrophages may be the major reservoir for HIV-1 in the solid tissues of HIV-1-infected individuals. Conflicting data have been reported, though, regarding the presence of HIV-1 provirus in peripheral blood monocytes isolated from HIV-1-seropositive humans. We have evaluated monocytes from the peripheral blood of eleven HIV-1-infected individuals utilizing a new, highly sensitive and specific in situ polymerase chain reaction. We demonstrate HIV-1 provirus in 73% (8/11) of these samples. None of these monocyte samples was demonstrated to contain cells expressing high levels of HIV-1-specific RNA, by standard in situ hybridization. The evaluation of the HIV-1 genome in peripheral blood monocytes of certain infected individuals may assist in the understanding of HIV-1 proviral latency and pathogenesis, in vivo.

Entities:  

Mesh:

Year:  1993        PMID: 8427715     DOI: 10.1089/aid.1993.9.69

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  12 in total

1.  T-cell induced pathogenesis in HIV: bystander effects and latent infection.

Authors:  D C Krakauer; M Nowak
Journal:  Proc Biol Sci       Date:  1999-05-22       Impact factor: 5.349

2.  Circulating monocytes are not a major reservoir of HIV-1 in elite suppressors.

Authors:  Adam M Spivak; Maria Salgado; S Alireza Rabi; Karen A O'Connell; Joel N Blankson
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

3.  DMP 323, a nonpeptide cyclic urea inhibitor of human immunodeficiency virus (HIV) protease, specifically and persistently blocks intracellular processing of HIV gag polyprotein.

Authors:  M M Rayner; B C Cordova; R P Meade; P E Aldrich; P K Jadhav; Y Ru; P Y Lam
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

4.  Placental trophoblasts resist infection by multiple human immunodeficiency virus (HIV) type 1 variants even with cytomegalovirus coinfection but support HIV replication after provirus transfection.

Authors:  R T Kilani; L J Chang; M I Garcia-Lloret; D Hemmings; B Winkler-Lowen; L J Guilbert
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

5.  Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency.

Authors:  Olaf Kutsch; Etty N Benveniste; George M Shaw; David N Levy
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 6.  Early versus delayed treatment of HIV infection. Zidovudine should be given before symptoms develop.

Authors:  D D Richman; D Havlir
Journal:  Drugs       Date:  1995       Impact factor: 9.546

7.  Monocyte maturation controls expression of equine infectious anemia virus.

Authors:  W Maury
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

8.  Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes.

Authors:  Mikhail A Gavrilin; Lawrence E Mathes; Michael Podell
Journal:  J Neurovirol       Date:  2002-06       Impact factor: 2.643

9.  Quantification of human immunodeficiency virus type 1-infected mononuclear cells in peripheral blood of seropositive subjects by newly developed flow cytometry analysis of the product of an in situ PCR assay.

Authors:  M C Re; G Furlini; D Gibellini; M Vignoli; E Ramazzotti; E Lolli; S Ranieri; M La Placa
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

Review 10.  Human immunodeficiency virus type 1 infection of the brain.

Authors:  W J Atwood; J R Berger; R Kaderman; C S Tornatore; E O Major
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.